Type of Posting: Revision Bulletin
Posting Date: 30–Jul–2010; updated 30–Jun–2011*
Official Date: 01–Sep–2010
Expert Committee: Monographs—Small Molecules 4
In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 4 Expert Committee has revised the Cetirizine Hydrochloride Oral Solution monograph. The purpose for the revision is to accommodate the sponsor's FDA-approved specification for the pH limits.
The Cetirizine Hydrochloride Oral Solution Revision Bulletin supersedes the currently official monograph and will be incorporated in the USP 34–NF 29.
Should you have any questions, please contact Domenick Vicchio, Ph.D. (301-998-6828 or DWV@usp.org).
* June 30, 2011 update: The Cetirizine Hydrochloride Oral Solution Revision Bulletin was originally scheduled to be incorporated in USP 34–NF 29.